CRPC w/ Bone Metastases - Results from #40

The current status of prophylactic femoral intramedullary nailing for metastatic cancer January 25, 2017

[Bone-specific therapy with radium-223 dichloride : Castration-resistant prostate cancer with symptomatic bone metastases] January 11, 2017

Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial December 13, 2016

Evaluation of bone metastases by 18F-choline PET/CT in a patient with castration-resistant prostate cancer treated with radium-223 December 5, 2016

SEOM Clinical Guideline for bone metastases from solid tumours (2016) December 1, 2016

Radium-223 and metastatic castration-resistant prostate cancer: All that glitters is not gold November 25, 2016

Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology November 24, 2016

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data November 22, 2016

Radium-223 Therapy of Bone Metastases in Prostate Cancer November 15, 2016

Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients November 3, 2016

Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases November 2, 2016

Cancer Cell Colonisation in the Bone Microenvironment November 2, 2016

Radium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case Presentation November 2, 2016

Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer November 1, 2016

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone November 1, 2016

[New progress of castration-resistant prostate cancer immunotherapy] October 3, 2016

Current therapeutic options targeting bone metastasis in metastatic castration resistant prostate cancer October 3, 2016

2016 ESMO Congress - Bayer to Showcase Latest Oncology Research September 28, 2016

Radium-223 Use in Clinical Practice and Variables Associated With Completion of Therapy September 28, 2016

68Ga-PSMA-11 PET as a gate-keeper for the treatment of metastatic prostate cancer with radium-223: proof of concept September 27, 2016

Page 3 of 10

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.